ProQR Therapeutics N.V. buy BiotechBee
Start price
07.09.22
/
70%
€0.81
Target price
31.12.24
€2.00
Performance (%)
72.58%
End price
09.12.22
€1.40
Summary
This prediction ended on 09.12.22 with a price of €1.40. The BUY prediction by BiotechBee for ProQR Therapeutics N.V. saw massive gains of 72.58%. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
ProQR Therapeutics N.V. | 0.217% | 0.217% | 26.352% |
iShares Core DAX® | -0.372% | 5.236% | 16.908% |
iShares Nasdaq 100 | -1.950% | 1.680% | 19.890% |
iShares Nikkei 225® | -1.690% | 7.286% | 12.202% |
iShares S&P 500 | -0.399% | 2.379% | 20.975% |
According to BiotechBee what are the pros and cons of ProQR Therapeutics N.V. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
Buy mit Kursziel 2,0
In the thread Trading ProQR Therapeutics N.V.
Buy beendet
Stopped prediction by BiotechBee for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€3.24
17.01.23
17.01.23
€5.00
31.12.25
31.12.25
-41.09%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year